The power of stress echocardiography and myocardial perfusion scintigraphy in predicting long-term outcome. Nothing lasts forever

Elhendy, Abdou

doi:10.1007/s12350-016-0621-1

Cited by 2 publications

(1 citation statement)

References 15 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two tests center on visualizing functional impairment in the myocardium, whereas one of these tests is capable of direct visualization of coronary artery lesions. The functional tests are radionuclide perfusion imaging (Sabharwal 2017) and stress echocardiography (Elhendy 2018). Both exams are performed during physical or pharmacologic stress and periods of rest to assess for reversible changes in myocardial perfusion or wall motion, respectively.…”

Section: G D Rubin (*)mentioning

confidence: 99%

Make Life Visible

Toyama¹,

Miyawaki²,

Nakamura³

et al. 2020

View full text Add to dashboard Cite

adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence and indicate if changes were made. The images or other third party material in this book are included in the book's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the book's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.

show abstract

Section: G D Rubin (*)mentioning

confidence: 99%

Make Life Visible

Toyama¹,

Miyawaki²,

Nakamura³

et al. 2020

View full text Add to dashboard Cite

show abstract

Coronary Heart Disease Diagnosis by FFRCT: Engineering Triumphs and Value Chain Analysis

Rubin

2019

Make Life Visible

View full text Add to dashboard Cite

Coronary heart disease is the leading cause of death throughout the developed world, yet the symptoms that patients experience as a result of coronary disease are often not specific. Determining who are the minority of patients with myocardial ischemia necessitating revascularization is a major activity of many medical centers. This task has traditionally fallen to coronary angiography, which is an expensive and invasive approach to identifying coronary artery lesions necessitating treatment through revascularization with stents or bypass grafts. Recently, computational fluid dynamic methods have been developed for cardiac CT that have been shown to effectively exclude patients from an invasive test when they do not have significant coronary artery disease. This manuscript reviews the technique of CTFFR and discusses some of the challenges of widespread clinical implementation through value chain analysis. 25.1 Coronary Heart Disease Pathophysiology Development of coronary heart disease occurs over many years with atherosclerotic plaque deposition beginning in childhood and gradually progressing to a stage that can result in narrowing of the coronary arteries that may restrict blood flow to the heart muscle, particularly during high demand such as during exercise. Diminished

show abstract

The power of stress echocardiography and myocardial perfusion scintigraphy in predicting long-term outcome. Nothing lasts forever

Cited by 2 publications

References 15 publications

Make Life Visible

Make Life Visible

Coronary Heart Disease Diagnosis by FFRCT: Engineering Triumphs and Value Chain Analysis

Contact Info

Product

Resources

About